<DOC>
	<DOCNO>NCT02513615</DOCNO>
	<brief_summary>Peritoneal dialysis ( PD ) type kidney replacement therapy patient chronic kidney disease peritoneal membrane use filter blood . Exposure PD fluid result scar peritoneal membrane increase blood vessel growth . This condition progress even peritoneal dialysis stop . Therefore , investigator hypothesize glucose dialysis fluid may result DNA modification call epigenetic change . These change modify gene express cell function . The investigator want study epigenetic change effect peritoneal membrane scarring , blood vessel growth peritoneal membrane function .</brief_summary>
	<brief_title>Epigenetic Determinants Peritoneal Fibrosis</brief_title>
	<detailed_description>There considerable evidence epigenetic change effector cell underlie progressive nature fibrogenic disease . The investigator develop ex-vivo mesothelial cell culture system base work Aroeira colleague . Ex vivo cell culture treat DNA methyltransferase inhibitor 5-AZA 72 hour . Overall , investigator find 11 14 patient ' cell show increase E-Cad/alpha-SMA ratio treatment 5-AZA , indicate return epithelial-like phenotype support epigenetic mechanism progressive fibrosis . The investigator hope identify DNA methylation pattern associate glucose exposure peritoneal membrane solute transport PD patient . The investigator take peritoneal effluent overnight dwell patient within one month initiation dialysis . The overnight effluent centrifuge pellet wash cell grown DMEM medium . At confluence , cell passaged 2 flask take DNA RNA . At 12 month , second overnight peritoneal effluent sample obtain . The investigator also gather demographic data ( patient 's age , diabetes , occurrence peritonitis , cumulative PD prescription include total glucose exposure , use icodextrin , result peritoneal equilibrium test carry clinical purpose 3 12 month start peritoneal dialysis ) . The investigator use whole genome DNA methylation analysis ass epigenetic change mesothelial cell incident PD patient .</detailed_description>
	<mesh_term>Fibrosis</mesh_term>
	<mesh_term>Peritoneal Fibrosis</mesh_term>
	<criteria>Patients end stage renal disease recently start peritoneal dialysis . Patients age 18 .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>Fibrosis</keyword>
	<keyword>Peritoneal Dialysis</keyword>
	<keyword>Epigenetics</keyword>
	<keyword>Peritoneal membrane injury</keyword>
	<keyword>Glucose exposure</keyword>
</DOC>